<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-25JXVA1X</identifier><date>1997</date><creator>Gwiezdzinski, Z...</creator><creator>Nierebinska, E...</creator><creator>Urbanowski, S...</creator><relation>documents/doc/2/URN_NBN_SI_doc-25JXVA1X_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-25JXVA1X_001.txt</relation><format format_type="issue">2</format><format format_type="volume">6</format><format format_type="type">article</format><format format_type="extent">str. 55-59</format><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="COBISSID_HOST">7338457</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-25JXVA1X</identifier><language>eng</language><publisher publisher_location="Ljubljana">Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">Administration and dosage</subject><subject language_type_id="slv">Candidiasis, oral</subject><subject language_type_id="slv">Candidiasis, vulvovaginal</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Follow-up studies</subject><subject language_type_id="slv">Itraconazole</subject><subject language_type_id="slv">Therapeutic use</subject><subject language_type_id="slv">Treatment outcome</subject><title>Itraconazole in the therapy of candidosis of uro-genital system and/or oral cavity and throat mucosa in a daily dose of 100 mg</title></Record>